New research identifies a protein, TIMP3, overproduced in age-related macular degeneration (AMD) that may drive the disease's progression. By targeting the enzyme linked to inflammation and drusen formation, scientists reduced early signs of AMD in stem cell models, offering hope for new treatments.
New research identifies a protein, TIMP3, overproduced in age-related macular degeneration (AMD) that may drive the disease's progression. By targeting the enzyme linked to inflammation and drusen formation, scientists reduced early signs of AMD in stem cell models, offering hope for new treatments.
Share this Article
Recommended